According to The Verge, the trial will focus on the company’s paralysis control devices and tech, and will last a total of six years. Neuralink is searching for humans aged over 22 years old with “quadriplegia due to vertical spinal cord injury or ALS” and have a “‘consistent and reliable caregiver’”; subjects will begin as participants in an 18-month study comprised of nine visits with researchers, followed by sessions of at least two hours a week involving brain-computer interface research and then 20 more visits during the next five years. Neuralink will provide compensation “for study-related costs” but did not reveal the location of the trial.
The PRIME Study will test the safety and efficacy of the N1 implant, Neuralink’s brain-computer device, the R1 robot which, will surgically implant the device, and the N1 User App, a software that will connect to the N1 implant and translate the signals of the brain to computer actions.
In related news, Musk shared a plan to charge all users of his X platform.